US Edition
NIH Halts DEI Policy; Over-the-Counter Ivermectin; Zicam, Orajel Product Recall
- On June 6, the maker of Zicam and Orajel swab products initiated a voluntary nationwide recall of all affected lots after detecting fungal contamination in the cotton components.
- The recall follows FDA findings of fungi in the swabs, which can cause serious blood infections, especially in children and immunocompromised users.
- The recall applies specifically to certain Zicam nasal swabs for cold relief and Orajel teething swabs for infants, while excluding all other products under the Zicam and Orajel brands.
- The FDA warns that the contamination could seriously endanger consumers' health and safety, advising individuals to discontinue use of the recalled products and request refunds at churchdwightrecall.com.
- Consumers nationwide and in Puerto Rico may return affected products for refunds, while the FDA monitors for adverse reactions and requests reports via its MedWatch program.
Insights by Ground AI
Does this summary seem wrong?
24 Articles
24 Articles
All
Left
5
Center
5
Right
4
MedPage TodayReposted by 
Anti-Aging, Acupuncture and Health News
Anti-Aging, Acupuncture and Health NewsNIH Halts DEI Policy; Over-the-Counter Ivermectin; Zicam, Orajel Product Recall
(MedPage Today) -- Note that some links may require registration or subscription. The NIH halted its policy requiring universities and research institutes to certify they do not have unlawful diversity, equity, and inclusion (DEI) programs or...
·New York, United States
Read Full Article
Coverage Details
Total News Sources24
Leaning Left5Leaning Right4Center5Last UpdatedBias Distribution36% Left, 36% Center
Bias Distribution
- 36% of the sources lean Left, 36% of the sources are Center
36% Center
L 36%
C 36%
R 29%
Factuality
To view factuality data please Upgrade to Premium
